A contemporary systematic review on liver transplantation for unresectable liver metastases of colorectal cancer.

"Conflicts of Interest Disclosure Rajiv Agarwal received a career development grant from the National Institutes of Health/National Cancer Institute (K12CA090625), honoraria for an American Society of Clinical Oncology (ASCO) Advantage program presentation (April 2021), and personal fees from Ipsen Biopharmaceuticals for the 2020 ASCO Gastrointestinal Cancers Symposium. Daniel B. Brown received research grants from Guerbet and Sirtex Medical. Kristen K. Ciombor reports research funds for Vanderbilt University Medical Center from BMS, Array, Incyte, Daiichi Sankyo, Nucana, AbbVie, Merck, Pfizer, Calithera, and Genentech; consulting fees from Array, Natera, Merck, Pfizer, Lilly/Loxo, Seagen, and Replimune; payments or honoraria for lectures and continuing medical education events from Research to Practice, the PCE Oncology Series, the Mayo Gastrointestinal Symposium, i3Health, OncLive, the MJH Life Sciences ctDNA (circulating tumor DNA [Deoxyribonucleic acid]) series, the LARVOL American Association for Cancer Research abstract discussion, Great Debates in GI Malignancies, the International Society of Gastrointestinal Oncology, Targeted Oncology, and the 2022 ASCO Gastrointestinal Cancers Symposium; flight/accommodation support for an advisory board meeting from Array (November 2019); and an unpaid leadership or fiduciary role with the Academic and Community Cancer Research United board of directors. The other authors made no disclosures."

"Funding Support No specific funding was disclosed."